These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2108084)

  • 21. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
    Holland KT; Taylor D; Farrell AM
    J Antimicrob Chemother; 1994 Jan; 33(1):41-55. PubMed ID: 8157573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid requirements of Staphylococcus aureus strains from Germany and Austria that produce toxic shock syndrome toxin-1 (TSST-1).
    Dickgiesser N; Eppli P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):1-7. PubMed ID: 3394445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion.
    Mills JT; Parsonnet J; Tsai YC; Kendrick M; Hickman RK; Kaśs EH
    J Infect Dis; 1985 Jun; 151(6):1158-61. PubMed ID: 3998512
    [No Abstract]   [Full Text] [Related]  

  • 24. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study.
    Kass EH; Schlievert PM; Parsonnet J; Mills JT
    J Infect Dis; 1988 Jul; 158(1):44-51. PubMed ID: 3134495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.
    Robbins RN; Reiser RF; Hehl GL; Bergdoll MS
    J Clin Microbiol; 1987 Aug; 25(8):1446-9. PubMed ID: 3624442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
    Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
    Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
    Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
    Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of enterotoxins and toxic shock syndrome toxin by Staphylococcus aureus isolated from bovine mastitis in Brazil.
    Cardoso HF; Silva N; Sena MJ; Carmo LS
    Lett Appl Microbiol; 1999 Nov; 29(5):347-9. PubMed ID: 10664976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pathogenesis of toxic shock syndrome.
    Kass EH; Parsonnet J
    Rev Infect Dis; 1987; 9 Suppl 5():S482-9. PubMed ID: 3317745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium and the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.
    Tierno PM; Hanna BA
    J Infect Dis; 1986 May; 153(5):994-6. PubMed ID: 3701112
    [No Abstract]   [Full Text] [Related]  

  • 35. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus under aerobic and anaerobic conditions and the effect of magnesium ion limitation.
    Taylor D; Holland KT
    Rev Infect Dis; 1989; 11 Suppl 1():S151-6. PubMed ID: 2928631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N; Wallach U
    Infection; 1987; 15(5):351-3. PubMed ID: 3692606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.